Ipilimumab

Common brands: Yervoy, Opdivo, Carboplatin, Kyxata, Prednisone

Top reporter: E.R. Squibb & Sons, L.L.C.

CTLA-4-directed Blocking Antibody [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Corticosteroid [EPC]Platinum-based Drug [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
42,014
Total Reports
22,225
Serious Reports
9,368
Death Reports
30
Reported Reactions
Death Report Ratio: High (22.30%)

Patient Demographics

Male
22,910
Female
12,787

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ipilimumab.

# Reaction Reports % of Total
1 DEATH 4,305
10.5%
2 MALIGNANT NEOPLASM PROGRESSION 3,717
9.0%
3 DIARRHOEA 3,095
7.5%
4 OFF LABEL USE 2,415
5.9%
5 COLITIS 2,282
5.5%
6 PYREXIA 2,024
4.9%
7 RASH 1,789
4.3%
8 FATIGUE 1,675
4.1%
9 NAUSEA 1,370
3.3%
10 INTENTIONAL PRODUCT USE ISSUE 1,348
3.3%
11 DECREASED APPETITE 1,104
2.7%
12 IMMUNE-MEDIATED ENTEROCOLITIS 1,067
2.6%
13 HYPOPHYSITIS 1,063
2.6%
14 VOMITING 1,044
2.5%
15 DYSPNOEA 998
2.4%
16 PNEUMONIA 961
2.3%
17 PNEUMONITIS 951
2.3%
18 ADVERSE EVENT 940
2.3%
19 ADRENAL INSUFFICIENCY 917
2.2%
20 PRURITUS 905
2.2%
21 ACUTE KIDNEY INJURY 855
2.1%
22 HYPOTHYROIDISM 824
2.0%
23 HEADACHE 803
1.9%
24 ASTHENIA 714
1.7%
25 ANAEMIA 709
1.7%
26 MALAISE 687
1.7%
27 DEHYDRATION 676
1.6%
28 DRUG INEFFECTIVE 653
1.6%
29 WEIGHT DECREASED 653
1.6%
30 SEPSIS 637
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.